Open AccessEfficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation
Author(s) -
AYŞE KARATAŞ,
HAKAN GÖKER,
HALUK DEMİROĞLU,
ÜMİT YAVUZ MALKAN,
MUSTAFA VELET,
OLGU ERKİN ÇINAR,
BATUHAN ERDOĞDU,
MİNE KARADENİZ,
NİLGÜN SAYINALP,
SALİH AKSU,
İbrahim C. Haznedaroğlu,
OSMAN İLHAMİ ÖZCEBE,
Yahya Büyükaşık
Publication year - 2022
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.55730/1300-0144.5328
Subject(s) - eltrombopag , medicine , haematopoiesis , stem cell , immune thrombocytopenia , platelet , genetics , biology
Thrombocytopenia is a common complication following hematopoietic stem cell transplantation (HSCT). Eltrombopag has been used in thrombocytopenia treatment after HSCT in recent years. Herein, we present our experience of 25 patients treated with eltrombopag for post-HSCT thrombocytopenia.